Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E0SW
|
||||
| Former ID |
DAP000611
|
||||
| Drug Name |
Enoximone
|
||||
| Synonyms |
Enoximona; Enoximonum; Fenoximone; Perfan; Perfane; Enoximona [Spanish]; Enoximonum [Latin]; E 1279; MDL 17,043; MDL-17043; Perfan (TN); RMI-17043; Enoximone (USAN/INN); Enoximone [USAN:BAN:INN]; MDL-17,043; 1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one; 1,3-Dihydro-4-methyl-5-[4-methylthiobenzoyl]-2H-imidazol-2-one; 4-Methyl-5-(p-(methylthio)benzoyl)-4-imidazolin-2-one; 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Congestive heart failure [ICD9: 428; ICD10:I50] | Approved | [536361] | ||
| Therapeutic Class |
Cardiotonic Agents
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H12N2O2S
|
||||
| Canonical SMILES |
CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC
|
||||
| InChI |
1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)
|
||||
| InChIKey |
ZJKNESGOIKRXQY-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 77671-31-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
7979168, 8183256, 11111134, 12012687, 14749775, 17397999, 17404973, 24278408, 34717755, 46505575, 47349356, 49979887, 50106183, 50106184, 53777516, 56320891, 56320892, 56463672, 57313564, 72605057, 80499070, 85231030, 90340640, 92303896, 92720042, 103558877, 104098757, 104302889, 109692969, 117501074, 121361146, 124749693, 124800754, 124880015, 125823798, 126620365, 126668388, 129911380, 134222996, 134337902, 134341085, 135011523, 137128402, 144203688, 144224578, 160967827, 162178954, 163123997, 163564364, 164814650
|
||||
| SuperDrug ATC ID |
C01CE03
|
||||
| SuperDrug CAS ID |
cas=077671319
|
||||
| Target and Pathway | |||||
| Target(s) | Phosphodiesterase (PDE) 3 | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.